A Phase I Multi-Cohort Trial of Pembrolizumab (MK-3475) in Combination with Backbone Treatments for Subjects with Multiple Myeloma. - Regional Cancer Care Associates LLC

Clinical Trials

A Phase I Multi-Cohort Trial of Pembrolizumab (MK-3475) in Combination with Backbone Treatments for Subjects with Multiple Myeloma.

Type of Cancer
Multiple Myeloma
Locations
Freehold
Howell
Little Silver
Sponsor
Merck
Protocol Number
3475-023 KEYNOTE
Cancer Diagnosis
To Learn More Call
201-510-0910